Literature DB >> 9850046

Propagation of genetically altered tumor cells derived from fine-needle aspirates of primary breast carcinoma.

Z Li1, V Bustos, J Miner, E Paulo, Z H Meng, G Zlotnikov, B M Ljung, S H Dairkee.   

Abstract

Because primary breast tumors are diagnosed earlier in the clinic, procurement of sufficient amounts of tumor tissue for in-depth biological characterization is becoming increasingly difficult. We demonstrate here that relatively small numbers of tumor cells within samples of fine-needle aspirates (FNA) can be propagated in culture. Of 25 cases attempted, 12 were passageable, resulting in up to 10(7) viable cells. FNA-derived cultures were evaluated for anchorage-independence, c-erb-B2 overexpression, aneusomy, and pattern of allelic loss. In every case examined, the cultured cells closely resembled the original tumor tissue and displayed one or more tumor phenotypes. The incidence of erb-B2 overexpressing tumors was similar in passageable and nonpassageable cases (33% versus 31%, respectively). FNAs that are expanded from a wide range of clinical breast material could be useful for functional studies presently limited to rare established cell lines, such as aberrant signal transduction and gene regulation, and for testing potential anticancer vaccines and drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850046

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells.

Authors:  Shanaz H Dairkee; Aejaz Sayeed; Gloria Luciani; Stacey Champion; Zhenhang Meng; Lakshmi R Jakkula; Heidi S Feiler; Joe W Gray; Dan H Moore
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

Review 2.  Culture models of human mammary epithelial cell transformation.

Authors:  M R Stampfer; P Yaswen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

3.  Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.

Authors:  Nancy Santos-Martínez; Lorenza Díaz; David Ordaz-Rosado; Janice García-Quiroz; David Barrera; Euclides Avila; Ali Halhali; Heriberto Medina-Franco; María J Ibarra-Sánchez; José Esparza-López; Javier Camacho; Fernando Larrea; Rocío García-Becerra
Journal:  BMC Cancer       Date:  2014-03-29       Impact factor: 4.430

4.  Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.

Authors:  Janice García-Quiroz; Rocío García-Becerra; David Barrera; Nancy Santos; Euclides Avila; David Ordaz-Rosado; Mariana Rivas-Suárez; Ali Halhali; Pamela Rodríguez; Armando Gamboa-Domínguez; Heriberto Medina-Franco; Javier Camacho; Fernando Larrea; Lorenza Díaz
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

Review 5.  Breast cancer cell lines: friend or foe?

Authors:  Sarah E Burdall; Andrew M Hanby; Mark R J Lansdown; Valerie Speirs
Journal:  Breast Cancer Res       Date:  2003-02-03       Impact factor: 6.466

6.  A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue.

Authors:  Shanaz H Dairkee; Youngran Ji; Yong Ben; Dan H Moore; Zhenhang Meng; Stefanie S Jeffrey
Journal:  BMC Genomics       Date:  2004-07-19       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.